Physician
Plastic Surgery
Dr. Joel E. Borkow works in the field of Plastic Surgery. He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Joel Borkow is a published physician. He published 1 publication, including: 'The tensiometric properties of expanded guinea pig skin.' He is registered with Medicare and accepts Medicare payments.
Publications
Schools
Dalhousie University Faculty of Medicine
Dalhousie Affil Hoss
Med College Ohio
Millard Fillmore Hospital
Procedures Preformed
- Adjacent Tissue Transfer
- Breast Reconstruction
- Destruction of Benign Skin Lesion
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- View All
Conditions Treated
- Benign Skin Lesion
- Gynecomastia
- Hidradenitis
- Second-Degree Burns
- View All
Doctors Specialties
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Select
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- CoreSource
- Coventry Health America PPO
- First Health (Coventry Health Care) PPO
- Geisinger Health Plan
- Community Blue PPO
- Choice Care PPO
- Medical Mutual of Ohio
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- UPMC PPO
- UPMC Health Plan
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
Dalhousie University Faculty of Medicine
Drug Facts
NPI NUMBER |
|
1063575421 |
NPPES Provider LastName |
|
BORKOW |
NPPES Provider FirstName |
|
JOEL |
NPPES Provider ZIPCode |
|
159011651 |
NPPES Provider State |
|
PA |
Specialty Description |
|
Plastic and Reconstructive Surgery |
Total Claim Count |
|
242.0 |
Distinct Opioid Count |
|
2.0 |
Opioid Claim Count |
|
38.0 |
Percent Opioid Claims |
|
15.7 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1063575421 |
Last Name Of The Provider |
BORKOW |
First Name Of The Provider |
JOEL |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog